Phase I-II

THE FUTURE OF CLINICAL TRIALS

Industry veteran suggests solutions to strengthen clinical care

10-May-2021 By Jenni Spinner

In this second part of a series on the state of clinical research, a leader from Javara lays out ideas to bring clinical research and care closer together.

Science 37 to merge with LifeScience Acquisition II

07-May-2021 By Jenni Spinner

The newly formed company (valued at $1.05b USD) will center on funding the firm’s decentralized trial technology platform and exploring new opportunities,

Florence lands $80m investment to grow remote trial tech

06-May-2021 By Jenni Spinner

In the face of increasing demand for decentralized clinical trials and remote technology, the company has received funding to enable its further expansion.

Sponsors must rethink ‘primitive’ clinical trial approaches: Phesi

04-May-2021 By Jenni Spinner

A leader from the clinical development services provider recommends using industry modal values to avoid protocol amendments, enrollment problems and more.

Latest FDA COVID-19-related advice and actions

04-May-2021 By Jenni Spinner

The US agency continues to keep a watchful eye over the nation’s pandemic response, issuing advice to professionals and taking action where appropriate.

Finding the right partners key to decentralized trials: Illingworth

03-May-2021 By Jenni Spinner

A leader from the mobile research nursing specialist offers advice on what to look for in a service provider, and why finding the right one is vital.

THE FUTURE OF CLINICAL TRIALS

Stronger connections between clinical care, research key to progress: Javara

29-Apr-2021 By Jenni Spinner

In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.

Tapping into ePRO yields cost, accuracy benefits: Phastar

29-Apr-2021 By Jenni Spinner

A leader from the CRO talks about increased use of electronic patient-reported outcomes in research, challenges of adoption, and how ePRO benefits trials.

PureTech hails new avenue for Alzheimer’s disease treatment

29-Apr-2021 By Jane Byrne

Preclinical research, published in Nature, suggests a new avenue for Alzheimer’s disease (AD) treatment, through restoring lymphatic flow in the brain

ERT, Bioclinica merger unites clinical trial tech teams

28-Apr-2021 By Jenni Spinner

The combination of companies brings together ERT’s clinical endpoint data capabilities and Bioclinica’s imaging, eClinical and drug-safety solutions.

‘We need to change the current clinical trial infrastructure’: Medable

27-Apr-2021 By Jenni Spinner

The company’s new chief scientific officer, a 30-year industry veteran, shares her informed thoughts on the future direction of the research field.

Nanoform, Aprecia partner on 3D-printed nanomedicines

27-Apr-2021 By Jenni Spinner

The two companies plan to collaboratively explore ways to combine 3D printing and nanotechnology, in order to create nanoparticle-enabled dosage forms.

CRAACO

CRAACO tackles ways to strengthen care, patient connection

26-Apr-2021 By Jenni Spinner

The 6th annual Clinical Research as a Care Option conference, taking place April 26-27, brings together experts seeking solutions to elevate the industry.

Cancer detection tech uses AI, whole-genome sequencing

22-Apr-2021 By Jenni Spinner

An advanced cancer detection platform from C2i Genomics (reportedly capable of spotting miniscule traces of the disease) recently landed $100m in funding.

Direct-to-patient services keep trials moving forward

22-Apr-2021 By Jenni Spinner

Leaders from AmerisourceBergen's World Courier and Lash Group tell how bringing trial supplies and services to patients can boost recruitment and retention.

Study explores synthetic cannabinoid for cancer-related anorexia

20-Apr-2021 By Jenni Spinner

Artelo Biosciences is investigating the viability of its novel cannabinoid product as a solution to treat cancer-related anorexia in oncology patients.

Immunomics firm reels in $14m to advance drug discovery

20-Apr-2021 By Jenni Spinner

ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology.

Syneos, Science 37 join to accelerate decentralized trials

20-Apr-2021 By Jenni Spinner

The two technology companies plan to work together to provide a unified platform that serves to streamline workflow, RWE generation and data harmonization.

FHIR can help tackle daunting digital challenges in research

19-Apr-2021 By Jenni Spinner

A leader from digital health solutions firm CitiusTech suggests use of fast healthcare interoperability resources is useful in the face of evolving tech.

Canine cancer research startup impacts treatment in humans

19-Apr-2021 By Jenni Spinner

One Health’s FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.

UK launches human challenge trial on COVID-19 reinfection

19-Apr-2021 By Rachel Arthur

A human challenge trial has been launched in the UK to investigate what happens when people who have already had COVID-19 are infected a second time.

Thermo Fisher Scientific snaps up PPD in $17.4b acquisition deal

15-Apr-2021 By Jenni Spinner

The science service and technologies firm plans to bring the CRO under its Laboratory Products and Services Segment umbrella after the deal is completed.

Decentralized trial model pushing research to ‘new standard’: AiCure

13-Apr-2021 By Jenni Spinner

A leader from the trial tech firm says COVID-19 has accelerated virtual studies, creating opportunities to improve patient engagement, costs and data.

PPD, Clinical Ink join on lupus assessment and endpoint data

13-Apr-2021 By Jenni Spinner

The two companies have partnered to develop a systemic erythematosus assessment review to streamline clinical trials centered on the autoimmune disease.

Decentralized trials call for supply chain flexibility: Marken

12-Apr-2021 By Jenni Spinner

Leaders from the supply chain solutions company share their thoughts on challenges associated with virtual and hybrid trials, and the COVID-19 pandemic.

Positive study results said to support deployment of assay system in cancer drug clinical trials

12-Apr-2021 By Jane Byrne

New research findings suggest that an immunotherapy assay enables determination of PD-L1 status in a high percentage of cancer patients and could guide personalized treatment selection.

CISCRP event to boost public awareness of clinical research

08-Apr-2021 By Jenni Spinner

The AWARE for All virtual event series aims to educate and engage the public as important partners in clinical trials and development of new treatments.

Charles River, Valence Discovery partner on AI-aided drug design

08-Apr-2021 By Jenni Spinner

The collaboration will enable Charles River clients to access Valence’s artificial intelligence platform in their pharmaceutical development projects.

Patient centricity vital to advancing rare-disease treatments: ICON

07-Apr-2021 By Jenni Spinner

A leader from the global CRO discusses how putting the patient first in clinical research is essential to discovering new therapies for orphan diseases.

Patient-centric approach more important than ever: Deloitte

07-Apr-2021 By Jenni Spinner

Especially with the COVID-19 pandemic impacting studies, the company says, putting patients at the center of studies and trial tech must be top priority.

Dedicated dad hopes to run down cure for a rare disease

07-Apr-2021 By Jenni Spinner

A father of two boys with Duchenne muscular dystrophy is running the Austin Marathon to raise funds toward pursuit of a cure for the rare, fatal disease.

Dive into advanced data, ethical issues at free online event

05-Apr-2021 By Jenni Spinner

The April 6 webinar, Clinical Development Innovations, will touch upon artificial intelligence, machine learning, ethics and other impactful issues.

PRA ‘toolkit’ pinpoints rare-disease clinical trial risks

05-Apr-2021 By Jenni Spinner

The free Patient-Centric Trial Development Toolkit is aimed toward helping sites and sponsors identify and minimize risks in rare-disease clinical studies.

IQVIA completes acquisition of Q2 Diagnostics

05-Apr-2021 By Jenni Spinner

The clinical research tech specialists, which had held 60% of Q2 Diagnostics, will now wholly own the comprehensive clinical laboratory services company.

AI algorithm automates analysis of cystic fibrosis scans

30-Mar-2021 By Jenni Spinner

Artificial intelligence software company Thirona has released PRAGMA-AI, technology that automates and accelerates CT scans in cystic fibrosis analysis.

Pharma firms should harness synthetic data: Phesi report

30-Mar-2021 By Jenni Spinner

The first in a series of reports released by Phesi and Accenture points toward the benefits of increased use of synthetic data in clinical research.

CROs fighting for the future of clinical research: report

29-Mar-2021 By Jenni Spinner

According to a Veeva Systems survey, contract research organizations are working to ensure clinical trials keep going during the COVID-19 era and beyond.

Clinical innovation webinar to feature award-winning technology

29-Mar-2021 By Jenni Spinner

An expert speaking at the April 6 Clinical Development Innovations event will discuss an app that matches patients with clinical research opportunities.

Rare-disease researchers face unique obstacles: Minoryx

29-Mar-2021 By Jenni Spinner

A representative of the rare-disease specialist firm outlines the unique obstacles of orphan CNS disease research, and how professionals can overcome them.

Life-sciences pros believe in potential of AI, blockchain: survey

25-Mar-2021 By Jenni Spinner

A survey by the Pistoia Alliance indicates most professionals believe the tech can accelerate R&D, but companies are stymied by a skills gap and data bias.

Merck to partner with SignalChem on Keytruda combo trial

25-Mar-2021 By Jenni Spinner

The two companies will work together to evaluate the combination of SLC-391 and Keytruda in treating patients with advanced non-small cell lung cancer.

Collecting patient data challenging in evolving trial landscape

24-Mar-2021 By Jenni Spinner

Two experts from CRO Phastar talk about how trial professionals face new, ever-changing challenges regarding collecting and disseminating patient data.

Medable advisory council works to amplify patient voice, inclusivity

24-Mar-2021 By Jenni Spinner

The company’s Patient Advisory Council brings together a range of people and perspectives to help ensure increased diversity, inclusivity and engagement.

IQVIA expands reach of its decentralized trial solutions

24-Mar-2021 By Jenni Spinner

The company reports that its patient-centric virtual study technology currently is in use in more than 60 ongoing trials in over 40 different countries.

Online health communities connect patients, trial teams

23-Mar-2021 By Jenni Spinner

Health Union offers patients dealing with a range of conditions ways to connect with valuable information, research opportunities and each other online.

MedVector introduces patient enrollment expansion solution

23-Mar-2021 By Jenni Spinner

The company’s Prime-Control Technology is designed to help study teams expand their subject enrollment beyond the reach of their clinical trial sites.

Study: elderly multiple myeloma patients can avoid long-term steroid use

22-Mar-2021 By Jenni Spinner

The results of a recent Phase III study show caregivers can gauge by individual age, functional status to adapt treatment approaches to specific patients.

ObvioHealth, RedHill Biopharma kick off remote COVID-19 trial

22-Mar-2021 By Jenni Spinner

The companies are joining on a hybrid clinical trial to test a potential COVID-19 treatment, featuring an ambitious remote patient monitoring strategy.